Metformin decreased tumor Ki-67, phospho-AMPK, phospho-Akt, phospho-rpS6, phospho-4E-BP-1 and ER but did not change PR levelResponders had increased serum free fatty acids and tumor staining for markers of fatty acid oxidation and glycogen synthesis. This evidence concerns the gene MKI67 and neoplasm.